What type of drug is sotagliflozin?
•
3 min read
In 2023, the FDA approved sotagliflozin, marketed as Inpefa, for reducing the risk of cardiovascular death and hospitalization in adults with heart failure. Understanding what type of drug is sotagliflozin is key to recognizing its unique pharmacological profile.
